The results of the SUSTAIN 7 trial comparing the efficacy of Novo Nordisks semaglutide with Eli Lillys Trulicity (dulaglutide), already in the market, have revealed that Novos drug seems to be better at helping patients with type 2 diabetes control their blood sugar levels and reduce weight
The Other Weekly Powerhouse: Tirzepatide Following closely on the heels of Semaglutide's success is Tirzepatide, another formidable player in the metabolic health space
RunClub Get more running stories join RunClub Daily running news, a community of 300,000+ runners, free training plans for every distance, and a daily running game
With LifeRx.md , getting GLP-1 without insurance is simple, affordable, and completely transparent
The findings suggest that mitochondrial fission and fusion may play a role in the regulation of mitochondrial biogenesis